PGR and invasive ductal breast carcinoma: At enrollment, 85.9% of patients (n = 450) had an invasive ductal carcinoma, 49.2% (n = 230) had node involvement, and 79.5% (n = 415) were positive for either estradiol or progesterone receptors.